30 Dec 2024 Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes Multiple categories
23 Dec 2024 Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis Member news
05 Dec 2024 BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data Multiple categories
23 Aug 2024 Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Member news
22 Aug 2024 A potential new oral drug for leishmaniasis has successfully been tested in healthy humans Member news
17 Jun 2024 Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 Member news
03 Apr 2024 Strong data from Sequana Medical's DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure Member news
25 Mar 2024 Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
